 |
|
Central Serous Chorioretinopathy After Local Application of Glucocorticoids for Skin Disorders
Arch Ophthalmol. 2004;122:784-786.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Central serous chorioretinopathy (CSCR) is a common disease characterized by the accumulation of subretinal fluid at the posterior pole of the fundus; it typically affects young and middle-aged adults, with men affected more commonly than women. The exact pathogenic mechanism of CSCR remains unclear. There is accumulating evidence that both endogenous and exogenous glucocorticoids may be implicated in the pathogenesis of the disease.1-2 Regarding the role of exogenous glucocorticoids, CSCR has been reported as a complication of intravenous, intramuscular, oral, epidural, inhaled, and intranasal glucocorticoid administration.2 We describe 2 patients who developed CSCR after prolonged treatment with glucocorticoids applied locally to the skin for dermatological indications.
Report of Cases.
Case 1. A 32-year-old man complained of decreased vision and metamorphopsia in the right eye. Best-corrected visual acuity was 20/25 OD and 20/20 OS. Fundus examination results were normal in the left eye but in the right eye revealed a well-circumscribed, shallow, serous . . . [Full Text of this Article]
Comment.
Panagiotis Karadimas, MD;
Anastasios Kapetanios, MD;
Evrydiki A. Bouzas, MD
Athens, Greece
Corresponding author: Panagiotis Karadimas, MD, Medical Retina Unit, First Department of Ophthalmology, Henry Dunant Hospital, 107 Mesogion Ave, 11526 Athens, Greece (e-mail: t_karadimas@yahoo.com).
|
